A randomized phase III trial of IV carboplatin and paclitaxel × 3 courses followed by observation versus weekly maintenance low-dose paclitaxel in patients with early-stage ovarian carcinoma: A Gynecologic Oncology Group Study-Reference-Cited by-同舟云学术

A randomized phase III trial of IV carboplatin and paclitaxel × 3 courses followed by observation versus weekly maintenance low-dose paclitaxel in patients with early-stage ovarian carcinoma: A Gynecologic Oncology Group Study

Published:2011-07 Issue:1 Volume:122 Page:89-94
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Mannel Robert S.,Brady Mark F.,Kohn Elise C.,Hanjani Parviz,Hiura Masamichi,Lee Roger,DeGeest Koen,Cohn David E.,Monk Bradley J.,Michael Helen

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Oncology

Reference27 articles.

1. Adjuvant therapy in stage I and stage II epithelial ovarian cancer;Young;N. Engl. J. Med.,1990

2. Adjuvant treatment for early ovarian cancer: a randomized phase III trial of intraperitoneal 32P or intravenous cyclophosphamide and cisplatin: a Gynecologic Oncology Group study;Young;J. Clin. Oncol.,2003

3. Adjuvant treatment for early epithelial ovarian cancer results of two randomized clinical trials comparing cisplatin to no further treatment of chronic phosphate (32P). GICOG: Gruppo Interregionale Collaborativo in Ginecologia Oncologica;Bolis;Ann. Oncol.,1995

4. Randomized trial comparing cisplatin with radioactive phosphorus or whole-abdomen irradiation as adjuvant treatment of ovarian cancer;Vergote;Cancer,1992

5. International collaborative ovarian neoplasm trial I and adjuvant chemotherapy in ovarian neoplasm trial: two parallel randomized phase III trials of adjuvant chemotherapy in early-stage ovarian carcinoma;Trimbos;J. Natl Cancer Inst.,2003

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrated Multi-Omic Analysis Reveals Immunosuppressive Phenotype Associated with Poor Outcomes in High-Grade Serous Ovarian Cancer;Cancers;2023-07-17

2. Correlates of Taxane-Induced Neuropathy, an Electronic Health Record Based Observational Study;Cancers;2023-01-26

3. Epithelial ovarian cancer;DiSaia and Creasman Clinical Gynecologic Oncology;2023

4. The clinical and prognostic significance of pre-chemotherapy serum CA-125 in high-risk early stage ovarian cancer: An NRG/GOG ancillary study;Gynecologic Oncology;2022-12

5. Efficacy and Safety of Placebo During the Maintenance Therapy of Ovarian Cancer in Randomized Controlled Trials: A Systematic Review and Meta-analysis;Frontiers in Oncology;2022-05-25